• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Klaria Pharma Holding

0.80 SEK+1.14 %17.7. klo 18.25
Less than 1K followers

KLAR

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.14 %
+1.01 %
-21.61 %
-15.82 %
+19.82 %
+38.06 %
+34.20 %
-89.58 %
-82.54 %

Klaria Pharma Holding operates in the pharmaceutical industry. The business is focused on developing and commercializing solutions in the therapeutic areas of migraine and cancer-related pain. The technology is based on the company's drug-delivery platform, where the product consists of an alginate-based polymer film. The film is attached to the patient's oral mucosa, which enables the distribution of drugs in the body. The headquarters are located in Uppsala.

Read more
Market cap
196.29M SEK
Turnover
387.1K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
27.8.
2026

Interim report Q2'26

26.11.
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release26.06.2026 klo 14.22

Report from the Annual General Meeting of Klaria Pharma Holding AB (publ)

Klaria Pharma Holding
Regulatory press release05.06.2026 klo 23.48

Klaria Pharma Holding AB: Klaria Annual Report 2025

Klaria Pharma Holding
Regulatory press release05.06.2026 klo 21.13

Klaria Pharma Holding AB: Klaria receives 25 MSEK in loan financing with the possibility of an additional 15 MSEK

Klaria Pharma Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release29.05.2026 klo 14.28

Klaria Pharma Holding AB: Klaria Interim Report Q1 2026

Klaria Pharma Holding
Regulatory press release28.05.2026 klo 09.35

Klaria Pharma Holding AB: Klaria adjusts annual report release date

Klaria Pharma Holding
Regulatory press release25.05.2026 klo 13.51

Summons to the Annual General Meeting of Klaria Pharma Holding AB (publ)

Klaria Pharma Holding
Regulatory press release22.05.2026 klo 13.01

Klaria Pharma Holding AB: Klaria postpones interim Q1 report

Klaria Pharma Holding
Regulatory press release21.05.2026 klo 22.09

Klaria Pharma Holding AB: Klaria postpones publication of the annual report

Klaria Pharma Holding
Regulatory press release23.04.2026 klo 10.56

Notice of the Annual General Meeting of Klaria Pharma Holding AB (publ)

Klaria Pharma Holding
Regulatory press release05.04.2026 klo 17.56

Klaria Pharma Holding AB: Annula Genernal Meeting Date Change:  Klaria Pharma Holding (publ)

Klaria Pharma Holding
Regulatory press release19.03.2026 klo 21.41

Correction: Incorrect inclusion of MAR text in earlier release.Summary of extraordinary general meeting in Klaria Pharma Holding AB (publ)

Klaria Pharma Holding
Regulatory press release19.03.2026 klo 17.16

Summary of extraordinary general meeting in Klaria Pharma Holding AB (publ)

Klaria Pharma Holding
Regulatory press release02.03.2026 klo 14.33

Klaria Pharma Holding AB (publ) Summons to Extraordinary General Meeting

Klaria Pharma Holding
Regulatory press release20.02.2026 klo 17.00

Klaria Pharma Holding AB: Klaria Year-End Report

Klaria Pharma Holding
Regulatory press release23.12.2025 klo 15.21

Klaria Pharma Holding AB: Klaria accelerates its business development work in collaboration with BDO

Klaria Pharma Holding
Regulatory press release17.12.2025 klo 14.24

Klaria Pharma Holding AB: Klaria Receives Positive Opinion on Sumatriptan Oral Film Patent Application

Klaria Pharma Holding
Regulatory press release26.11.2025 klo 18.00

Klaria Pharma Holding AB: Klaria Interim Report Q3 2025

Klaria Pharma Holding
Regulatory press release28.08.2025 klo 09.30

Klaria Pharma Holding AB: Klaria Interim Report Q2 2025

Klaria Pharma Holding
Regulatory press release03.07.2025 klo 11.30

Klaria Pharma Holding AB: Klaria stengthens patent portfolio of sumatriptan alginate film with new filing

Klaria Pharma Holding
Regulatory press release21.05.2025 klo 17.16

Klaria Pharma Holding AB: Klaria Interim Report

Klaria Pharma Holding